≡ Risteys
FG R12 + FR

Documentation Changelog GitHub Contact & Feedback
info icon

Malignant neoplasm of other and unspecified male genital organs, excluding all cancers (controls excluding all cancers)

Endpoint Browser

C3_MALE_GENITAL_NAS_EXALLC

Endpoint definition

↥

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

only males

226837

2. Check conditions

None

226837

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — C63
  • Hospital discharge: ICD-9 — 187
  • Hospital discharge: ICD-8 — 187
  • Cause of death: ICD-10 — C63
  • Cause of death: ICD-9 — 187
  • Cause of death: ICD-8 — 187
  • Cause of death: excluded ICD-9 — 187[1-4]
  • Cause of death: excluded ICD-8 — 1870
  • Cancer registry: Topography ICD-O-3 — C63
  • Cancer registry: Morphology ICD-O-3 — ANY
  • Cancer registry: Behaviour codes — 3

3 out of 7 registries used, show all original rules.

57

4. Check minimum number of events

None

57

5. Include endpoints

None

57

6. Filter based on genotype QC (FinnGen only)

57

Control definitions (FinnGen only)

Control exclude
C3_CANCER, C3_CANCER_WIDE_EXALLC

Extra metadata

First used in FinnGen datafreeze
DF12

Similar endpoints

↥

List of similar endpoints to Malignant neoplasm of other and unspecified male genital organs, excluding all cancers (controls excluding all cancers) based on the number of shared cases.

Venn diagram with an highlighted set fully inside another set Similar with more cases:

Venn diagram with a set fully inside an highlighted set Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

All Female Male
Number of individuals 57 - 57
Unadjusted period prevalence (%) 0.03 - 0.03
Median age at first event (years) 63.60 - 63.60

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

No data available

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
15
22
8.90
10.28
1.1
1.0
—
—
—
0
0
10
12
9.89
7.83
1.8
1.2
—
—
—
0
0
23
85
3.86
5.51
2.4
1.4
—
—
—
0
0
10
19
6.17
5.25
27.2
38.3
—
—
—
0
0
25
114
3.13
4.14
3.1
2.3
—
—
—
0
0
13
39
4.02
4.04
23.2
12.0
—
—
—
0
0
18
70
3.30
3.84
2.1
2.3
—
—
—
0
0
21
90
3.11
3.82
3.9
2.8
—
—
—
0
0
8
16
5.63
3.18
1.5
1.8
—
—
—
0
0
32
189
2.58
3.04
12.1
3.8
12.9
13.0
umol/l
0.02
32
178
13
48
3.21
2.95
23.5
19.9
0.3
1.1
mmol/l
0.29
13
36
24
125
2.59
2.94
8.7
3.9
—
—
—
0
0
20
96
2.67
2.87
5.0
2.3
—
—
—
0
0
21
104
2.61
2.83
5.0
2.5
1.1
0.6
e6/l
0.20
16
75
14
58
2.87
2.61
1.7
1.9
—
—
—
0
0
19
93
2.56
2.59
10.4
4.3
—
—
—
0
0
24
133
2.39
2.51
9.8
4.6
—
—
—
0
0
6
12
5.44
2.47
1.0
1.1
—
—
—
0
0
34
228
2.22
2.19
14.6
5.4
4.5
4.6
e9/l
0.10
29
199
17
85
2.42
2.19
2.9
3.3
—
—
—
0
0
21
117
2.26
2.12
5.2
2.5
238.8
136.8
e6/l
0.17
16
88
12
52
2.66
2.04
3.5
3.2
20.9
25.5
%
0.96
12
44
11
47
2.66
1.91
2.5
1.5
1.7
1.5
%
0.65
11
37
12
54
2.55
1.89
3.2
3.0
2.2
2.3
g/l
0.27
12
48
22
131
2.11
1.85
5.9
3.0
1629.5
22.8
e6/l
0.50
17
91
28
184
2.03
1.80
6.8
11.9
1.4
1.4
inr
—
7
48
29
197
1.96
1.67
9.8
4.9
0.0
0.0
e9/l
0.19
22
174
29
197
1.96
1.67
9.8
4.9
0.6
0.6
e9/l
0.09
22
171
5
14
3.81
1.65
20.0
3.6
—
—
—
0
0
7
26
2.92
1.64
1.0
1.5
—
—
—
0
0
6
20
3.23
1.63
2.8
2.5
—
—
—
0
0
29
199
1.93
1.61
10.6
5.2
2.8
1.8
e9/l
0.50
23
178
9
39
2.55
1.51
1.1
1.4
—
—
—
0
0
29
205
1.84
1.42
10.8
5.1
0.2
0.2
e9/l
0.35
22
178
9
42
2.35
1.41
1.4
2.0
—
—
—
0
0
35
263
1.86
1.41
4.9
3.4
—
—
—
0
0
10
50
2.21
1.25
6.0
4.1
—
—
—
0
0
12
65
2.07
1.25
3.7
2.8
11.5
14.6
umol/l
1.25
12
56
5
19
2.78
1.24
6.4
27.8
0.9
0.9
%
—
5
19
24
168
1.74
1.16
17.0
8.3
0.0
0.0
e9/l
0.00
18
133
7
32
2.35
1.12
1.6
1.3
57.2
65.1
g/l
—
7
25
5
21
2.51
1.11
6.4
25.6
1.9
1.4
%
—
5
21
9
48
2.04
1.07
5.0
3.7
-2.1
1.6
mmol/l
—
9
35
7
130
0.47
1.04
2.7
3.5
—
—
—
0
0
7
36
2.07
1.01
1.6
1.4
—
—
—
0
0
14
87
1.81
0.99
1.1
1.2
—
—
—
0
0
7
37
2.01
0.98
1.6
1.6
—
—
—
0
0
6
27
2.36
0.97
3.3
3.6
127.5
127.7
g/l
—
6
27
33
262
1.62
0.94
13.5
6.2
6.8
7.0
mmol/l
0.17
33
246
14
91
1.71
0.85
6.9
3.5
53.3
146.9
ng/l
0.61
14
78
6
32
1.98
0.84
5.8
19.1
—
—
—
0
0
8
48
1.77
0.83
1.9
1.8
—
—
—
0
0
0
27
0.00
0.79
0.0
2.3
—
—
—
0
0
35
406
0.64
0.79
5.8
5.4
2.4
2.5
mmol/l
0.16
35
368
38
320
1.56
0.78
41.4
15.1
14.2
13.7
%
1.22
38
311
10
152
0.59
0.75
3.7
3.2
11.6
101.1
mg/l
—
10
105
19
139
1.55
0.73
3.6
2.6
175.6
191.4
ug/l
0.08
19
126
5
28
1.86
0.68
9.6
3.9
19.0
23.9
mmol/l
—
5
23
5
85
0.55
0.62
5.0
3.4
—
1.0
—
0
8
0
22
0.00
0.60
0.0
4.1
—
3.4
—
0
15
6
36
1.74
0.59
1.0
1.3
—
—
—
0
0
34
294
1.39
0.51
4.8
4.0
—
—
—
0
0
7
100
0.66
0.44
4.3
2.7
—
—
—
0
0
18
143
1.38
0.44
3.1
3.1
—
—
—
0
0
5
32
1.62
0.43
6.8
5.1
87.6
109.3
ng/l
—
5
26
0
16
0.00
0.42
0.0
11.3
—
—
—
0
0
0
17
0.00
0.41
0.0
1.2
—
—
—
0
0
36
396
0.75
0.39
4.7
4.9
5.9
6.2
mmol/l
1.19
36
349
5
36
1.43
0.39
6.4
3.5
—
—
—
0
0
35
383
0.78
0.34
5.5
7.0
39.3
41.6
mmol/mol
1.08
35
350
7
52
1.39
0.33
4.0
3.0
5.4
9.3
ug/l
—
7
44
13
103
1.34
0.31
2.8
1.8
3.0
2.7
mg/l
0.25
13
85
38
348
1.28
0.31
45.6
14.6
39.9
41.4
%
0.58
30
225
8
64
1.29
0.29
2.3
4.3
—
—
—
0
0
7
94
0.71
0.24
3.1
1.9
1116.7
1146.7
nmol/l
—
7
71
5
40
1.27
0.23
1.2
1.4
—
283.3
—
0
12
5
41
1.24
0.22
3.2
3.2
—
—
—
0
0
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
15
131
1.20
0.16
3.3
4.6
—
—
—
0
0
11
97
1.17
0.10
2.1
1.8
654545808.2
387.2
pmol/l
0.47
11
76
17
181
0.91
0.05
2.4
2.0
97.1
91.7
pmol/l
—
9
110
41
419
0.92
0.04
28.4
12.7
—
—
—
0
0
45
447
1.03
0.00
46.6
19.2
91.6
91.3
fl
0.19
45
436
45
447
1.03
0.00
46.5
19.2
30.3
30.6
pg
0.55
45
436
43
427
1.03
0.00
43.6
17.8
4.0
4.0
mmol/l
0.50
43
412
45
447
1.03
0.00
47.0
19.4
130.9
140.8
g/l
2.46
45
437
43
426
1.04
0.00
42.6
17.8
139.8
139.6
mmol/l
0.09
43
412
0
8
0.00
0.00
0.0
1.9
—
4.2
—
0
8
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
0
8
0.00
0.00
0.0
1.9
—
105.1
—
0
8
0
8
0.00
0.00
0.0
1.9
—
—
—
0
0
0
8
0.00
0.00
0.0
3.1
—
—
—
0
0
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
2.0
—
332.8
—
0
5
0
5
0.00
0.00
0.0
2.4
—
—
—
0
0
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: C3_MALE_GENITAL_NAS_EXALLC – Malignant neoplasm of other and unspecified male genital organs, excluding all cancers (controls excluding all cancers)

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).